BioTechnology Stocks | There’s A Good Reason Investors Love These Shares
Biotechnology stocks offer investors the potential to profit from the next generation of treatments. And because treatments are vast—covering everything from serious illness to cosmetic enhancements, investors are afforded a lot of choices. Because of ... [Read]
PBYI Stock Nosedives: Puma Biotechnology’s Nerlynx Revenue Falls
PBYI stock is the biggest loser in the biotech sector after Puma Biotechnology Inc. (NASDAQ:PBYI) reported disappointing revenue for its only commercial product, Nerlynx. Nevertheless, the company posted improved loss and revenue for the fiscal ... [Read]
BioTime Stock: “Buy” Ratings Abound, Should You Take Note?
BioTime stock is currently selling for $1.18 USD on the NYSE American exchange. At the time of writing, shares are down nearly 5%. Despite a rough few trading days, BTX stock has a consensus rating ... [Read]
PDL BioPharma Shares Increased Today, But Investors Remain Skeptical About Company’s Growth
On Friday, biopharmaceutical royalty company PDL BioPharma Inc. (NASDAQ:$PDLI) saw its shares soar. It all started after the Nevada-based company reported positive second-quarter earnings. A quarterly net profit that was 827% higher than PDL BioPharma ... [Read]